Search

Search Constraints

You searched for: Author/Creator Totzeck, Andreas

Search Results

2. Eculizumab versus rituximab in generalised myasthenia gravis. Issue 5 (4th March 2022)

4. Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy. (October 2018)

5. Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study. (August 2021)

6. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Issue 4 (April 2020)

7. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023)

8. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2023)